Transplant and organ teams
Define an organ, donor context, comparator, perfusion conditions and function endpoints. Evaluate kidney, liver, heart and lung on their own terms.
BHOC Transplant welcomes focused work with groups that can define a protocol, run the measurements and evaluate the evidence. Potential collaboration is not an announced partnership.
The first practical route is organ-specific product characterization and controlled ex-vivo evaluation. Other paths need their own protocols.
Define an organ, donor context, comparator, perfusion conditions and function endpoints. Evaluate kidney, liver, heart and lung on their own terms.
Characterize oxygen affinity, temperature response, oxidation, stability and tissue-level readouts before testing any clinical promise.
Study possible compatibility with gene-edited donors, ex-vivo interventions or engineered grafts in separate studies. BHOC itself is not a genetic editing method.
Plan quality systems, safety work, manufacturing capacity and regulatory discussions appropriate to the product and setting.
Please include your organisation, role, organ or research setting, available methods and geographic scope. We can then discuss a defined next step.
No organisation is presented here as a current partner without confirmation.